𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comprehensive chromosome screening (CCS) with vitrification results in improved clinical outcome in women >35 years: a randomized control trial

✍ Scribed by W.B. Schoolcraft; E. Surrey; D. Minjarez; R.L. Gustofson; R.T. Scott Jr.; M.G. Katz-Jaffe


Book ID
116480578
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
47 KB
Volume
98
Category
Article
ISSN
1556-5653

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Interferon-Ξ± does not improve outcome at
✍ Carol M. Black; Alan J. Silman; Ariane I. Herrick; Christopher P. Denton; Helen πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 161 KB πŸ‘ 1 views

## Objective: To determine whether interferon-alpha (ifnalpha) reduces the severity of skin involvement in early (<3 years) diffuse scleroderma. ## Methods: In a randomized, placebo-controlled, double-blind trial, 35 patients with early scleroderma received subcutaneous injections of either ifnal

The vitamin D analogue 2MD increases bon
✍ Hector F DeLuca; Wendy Bedale; Neil Binkley; J Chris Gallagher; Michael Bolognes πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 215 KB πŸ‘ 1 views

## Abstract Most osteoporosis drugs act by inhibiting bone resorption. A need exists for osteoporosis therapies that stimulate new bone formation. 2‐Methylene‐19‐nor‐(20__S__)‐1Ξ±,25‐dihydroxyvitamin D~3~ (2MD) is a vitamin D analogue that potently stimulates bone formation activity in vitro and in